Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.002 USD | +0.46% | -4.33% | -15.12% |
Apr. 01 | Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 26 | Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule | MT |
Financials (USD)
Sales 2022 | 557K | Sales 2023 | 184K | Capitalization | 6.21M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -5M | EV / Sales 2022 | 15.6 x |
Net cash position 2022 | 2.75M | Net cash position 2023 | 6.2M | EV / Sales 2023 | 0.11 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.11
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.53% |
1 day | +0.46% | ||
1 week | -4.33% | ||
Current month | -2.20% | ||
1 month | -3.18% | ||
3 months | +31.38% | ||
6 months | -19.64% | ||
Current year | -15.12% |
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 22-08-14 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 23-10-11 |
Brynner Chiam
BRD | Director/Board Member | - | 23-10-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 7.002 | +0.46% | 8 617 |
24-04-24 | 6.97 | -0.57% | 2,582 |
24-04-23 | 7.01 | 0.00% | 1,329 |
24-04-22 | 7.01 | -4.23% | 604 |
24-04-19 | 7.32 | +3.09% | 2,979 |
Delayed Quote Nasdaq, April 26, 2024 at 10:22 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-15.12% | 6.37M | |
+25.86% | 653B | |
+27.00% | 556B | |
-6.48% | 354B | |
+20.48% | 331B | |
+3.87% | 296B | |
+13.15% | 233B | |
+5.61% | 201B | |
-9.49% | 193B | |
-6.32% | 144B |
- Stock Market
- Equities
- TTNP Stock